New User? Sign Up | Sign In

Insider Trading - Denali Therapeutics Inc. (DNLI)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
DNLI Insider Trading Transactions for Denali Therapeutics Inc.
Goto page 0, 1, 2, 3, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-11-22
Sale
2019-11-26
5:08 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
15,000 $18.02 $270,287 584,378
(Indirect
Direct)
View
2019-11-22
Sale
2019-11-26
6:17 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
43,485 $18.02 $783,574 2,450,572
(Indirect
Direct)
View
2019-12-03
Sale
2019-12-05
4:29 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
21,268 $18 $382,874 2,429,304
(Indirect
Direct)
View
2019-12-03
Sale
2019-12-05
5:16 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
7,500 $18 $135,017 25,839
(Indirect
Direct)
View
2019-12-19
Sale
2019-12-23
7:35 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
6,890 $20.01 $137,835 0
(Indirect
Direct)
View
2020-02-26
Sale
2020-02-28
4:25 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Crestline SI (GP) L.P.
Crestline Investors Inc.
Crestline Management LP
10% Owner
3,894,764 $20.25 $78,868,971 15,567,736
(Indirect)
View
2020-03-30
Sale
2020-04-01
6:17 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
4,807 $19.48 $93,640 22,013
(Indirect
Direct)
View
2020-03-30
Sale
2020-04-01
6:18 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
1,428 $19.48 $27,817 2,822
(Indirect
Direct)
View
2020-03-30
Sale
2020-04-01
6:19 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
1,427 $19.49 $27,812 28,662
(Indirect
Direct)
View
2020-03-30
Sale
2020-04-01
6:19 pm
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
1,428 $19.48 $27,817 1,006,488
(Direct)
View
2020-06-05
Sale
2020-06-09
4:10 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Crestline SI (GP) L.P.
Crestline Investors Inc.
Crestline Management LP
10% Owner
1,922,855 $25.75 $49,513,516 13,644,881
(Indirect)
View
2020-06-16
Sale
2020-06-18
9:41 pm
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
400,000 $26.1 $10,440,000 2,739,043
(Direct)
View
2020-06-19
Sale
2020-06-23
5:41 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
Neuro Line Partners LP
Bratton Capital Management L.P.
Bratton Capital Inc.
10% Owner
255,000 $24.72 $6,304,373 698,035
(Indirect)
View
2020-06-26
Sale
2020-06-30
7:17 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
Neuro Line Partners LP
Bratton Capital Management L.P.
Bratton Capital Inc.
10% Owner
250,000 $23.97 $5,993,052 448,035
(Indirect)
View
2020-08-12
Sale
2020-08-14
4:50 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Crestline SI (GP) L.P.
Crestline Investors Inc.
Crestline Management LP
10% Owner
1,443,247 $31.65 $45,678,767 12,201,634
(Indirect)
View
2020-09-10
Sale
2020-09-14
9:38 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
3,689 $31 $114,359 165,141
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-12-03
Exercise
2019-12-05
5:16 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
711 $5.28 25,839
(Direct)
View
2019-12-03
Exercise
2019-12-05
5:16 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
3,121 $5.28 25,839
(Direct)
View
2019-12-03
Exercise
2019-12-05
5:16 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
711 $5.28 25,839
(Direct)
View
2019-12-03
Exercise
2019-12-05
5:16 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
3,121 $5.28 25,839
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:01 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
29,874 $0 142,000
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:01 pm
N/A
2030-02-09
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
142,000 $24.81 142,000
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:02 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
78,787 $0 367,675
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:02 pm
N/A
2030-02-09
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
367,675 $24.81 367,675
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:03 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
29,143 $0 136,000
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:03 pm
N/A
2030-02-09
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
136,000 $24.81 136,000
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:03 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
29,143 $0 136,000
(Direct)
View
2020-02-10
Option Award
2020-02-12
6:03 pm
N/A
2030-02-09
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
136,000 $24.81 136,000
(Direct)
View
2020-02-08
Exercise
2020-04-01
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
5,515 $0 26,400
(Direct)
View
2020-02-08
Exercise
2020-04-01
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
8,800 $0 26,400
(Direct)
View
2020-02-08
Exercise
2020-04-01
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
5,515 $0 26,400
(Direct)
View
2020-02-08
Exercise
2020-04-01
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
8,800 $0 26,400
(Direct)
View
2019-02-07
Exercise
2020-04-01
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
4,250 $0 12,750
(Direct)
View
2019-02-07
Exercise
2020-04-01
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
4,250 $0 12,750
(Direct)
View
2020-02-07
Exercise
2020-04-01
6:15 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
4,250 $0 12,750
(Direct)
View
2020-02-07
Exercise
2020-04-01
6:15 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
4,250 $0 12,750
(Direct)
View
2020-02-07
Exercise
2020-04-01
6:16 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
4,250 $0 12,750
(Direct)
View
2020-02-07
Exercise
2020-04-01
6:16 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
4,250 $0 12,750
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:58 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Cole Douglas G.
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:58 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Cole Douglas G.
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:59 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Cook Jennifer E.
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:59 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Cook Jennifer E.
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI FLATLEY JAY T
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
N/A
Denali Therapeutics Inc. DNLI FLATLEY JAY T
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:01 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Klein Peter S
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:01 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Klein Peter S
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI NELSEN ROBERT
Director
10% Owner
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
N/A
Denali Therapeutics Inc. DNLI NELSEN ROBERT
Director
10% Owner
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI Schenkein David P
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:02 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schenkein David P
Director
3,253 $0 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:03 pm
N/A
2030-06-02
Denali Therapeutics Inc. DNLI SATO VICKI L
Director
15,183 $28.82 3,253
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:03 pm
N/A
N/A
Denali Therapeutics Inc. DNLI SATO VICKI L
Director
3,253 $0 3,253
(Direct)
View
2020-06-18
Gift
2020-06-18
9:42 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
40,000 $0 2,389,304
(Indirect)
View
2020-08-18
Option Award
2020-08-20
6:14 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
20,000 $0 20,000
(Direct)
View
2020-08-18
Option Award
2020-08-20
6:17 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
20,000 $0 20,000
(Direct)
View
2020-08-18
Option Award
2020-08-20
6:19 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
20,000 $0 20,000
(Direct)
View
2020-08-18
Option Award
2020-08-20
6:20 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
20,000 $0 20,000
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
5,643 $0 0
(Indirect)
View
2020-08-20
Tax Withholding
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
1,954 $32.87 0
(Indirect)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
5,643 $0 0
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,643 $0 0
(Indirect)
View
2020-08-20
Tax Withholding
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
1,954 $32.88 0
(Indirect)
View
2020-08-20
Exercise
2020-08-24
8:37 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,643 $0 0
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,643 $0 0
(Direct)
View
2020-08-20
Tax Withholding
2020-08-24
8:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
1,954 $32.88 0
(Direct)
View
2020-08-20
Exercise
2020-08-24
8:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,643 $0 0
(Direct)
View
Goto page 0, 1, 2, 3, Next